2023 Annual Meeting | C9 - Autoimmune Neurology: Paraneoplastic
12:15 PM - 12:50 PM EST | Speaker |
Overview of Paraneoplastic Syndromes and Diagnostic Tips
Marianna Spatola, MD, PhD |
12:50 PM - 01:25 PM EST | Speaker |
Neuropathological Findings and Implications for Diagnosis
Romana Hoeftberger |
01:25 PM - 02:00 PM EST | Speaker |
Pathogenic Mechanisms: Immunological Bases of Paraneoplastic Syndromes and Therapeutic Implications
Roland Liblau |
02:00 PM - 02:15 PM EST | Discussion |
Questions and Answers
Marianna Spatola, MD, PhD, Romana Hoeftberger, Roland Liblau |
Marianna Spatola, MD, PhD | The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III). The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. |
Romana Hoeftberger | Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun, Biogen, Sanofi-Aventis, and UCB Biopharma. |
Roland Liblau | Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-genzyme. Roland Liblau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Servier. Roland Liblau has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Immunology. The institution of Roland Liblau has received research support from Roche. The institution of Roland Liblau has received research support from ARSEP. The institution of Roland Liblau has received research support from Fondation pour la Recherche Médicale. The institution of Roland Liblau has received research support from Population Bio UK, Inc. The institution of Roland Liblau has received research support from ANR. |